Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07673679

GliomaAI-Astro4: MRI-Based Detection of IDH Mutant Astrocytoma Grade 4

Sponsor: Deep Learning Institute of Radiological Sciences

View on ClinicalTrials.gov

Summary

The goal of this observational study is to learn whether an artificial intelligence system called GliomaAI-Astro4 can help detect a specific molecular type of brain tumour called IDH mutant Astrocytoma Grade 4 using routine MRI scans. The study uses previously collected and fully anonymised MRI data from 1,372 patients from 13 institutions in the Cancer Imaging Archive (TCIA). The main questions it aims to answer are: * How accurately can GliomaAI-Astro4 identify IDH mutant Astrocytoma Grade 4 from MRI scans? * How well does the system perform across data from different hospitals and patient groups? Researchers will use existing MRI scans and clinical information to train and test the AI system. No new scans, treatments, or hospital visits are required for participants, and all data used is fully anonymised and obtained from an existing research database. Participants will not be asked to do anything, as this study only uses previously collected imaging data.

Official title: GliomaAI-Astro4: Non-Invasive MRI-Based Detection of IDH Mutant Astrocytoma Grade 4 Using Artificial Intelligence

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

1372

Start Date

2017-03-14

Completion Date

2021-06-16

Last Updated

2026-06-29

Healthy Volunteers

No

Interventions

DEVICE

GliomaAI-Astro4

Software as Medical Device (SaMD) for predicting IDH mutant astrocytoma grade 4

Locations (1)

Deep Learning Institute of Radiological Sciences

Mumbai, India